A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program

I J M Doull1, S J Hall, D M Bradley

  • 1Respiratory/Cystic Fibrosis Unit, Children's Hospital for Wales, Cardiff, Wales, United Kingdom. doullij@cf.ac.uk

Pediatric Pulmonology
|July 31, 2007
PubMed

Insights

This study presents a new sweat test protocol for early Cystic Fibrosis (CF) diagnosis in newborns. The protocol balances timely identification with parental support, showing high satisfaction rates.

Area of Science:

  • Medical Diagnostics
  • Pediatric Health
  • Genetic Disorders

Background:

  • Cystic Fibrosis (CF) is a genetic disorder requiring early detection for optimal management.
  • Newborn screening protocols aim to identify infants with CF shortly after birth.
  • Parental anxiety and the diagnostic timeline are critical considerations in CF screening.

Purpose of the Study:

  • To develop and evaluate a sweat test-centered protocol for Cystic Fibrosis diagnosis in newborns.
  • To optimize the early identification of infants with CF while minimizing parental uncertainty.
  • To assess parental satisfaction with the disclosure and diagnostic process.

Main Methods:

  • Implementation of a sweat test-centered protocol for newborn screening over a 9-year period.
  • Screening of 295,247 newborn infants for Cystic Fibrosis.
  • Analysis of diagnostic outcomes, including false negative rates.

Main Results:

  • 121 infants were diagnosed with Cystic Fibrosis.
  • A false negative rate of 3.3% (4 cases) was observed during the study period.
  • High parental satisfaction was reported 6 months after disclosure.

Conclusions:

  • The developed sweat test protocol facilitates early and effective diagnosis of Cystic Fibrosis in newborns.
  • The protocol successfully balances the need for prompt diagnosis with sensitive communication to parents.
  • The findings support the high parental satisfaction with the implemented screening and disclosure process.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...